Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.43
Delayed Data
As of Jan 20
 -0.01 / -0.13%
Today’s Change
4.21
Today|||52-Week Range
8.45
-4.01%
Year-to-Date
Why Exact Sciences' Stock Could Go Much Higher
Jan 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.44
Today’s open7.43
Day’s range7.39 - 7.62
Volume40,744
Average volume (3 months)117,391
Market cap$244.2M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)+5.71%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.33+5.53%
OXFDOxford Immunotec Glo...+0.01+0.07%
TRIBTrinity Biotech PLC-0.04-0.58%
LNTHLantheus Holdings In...+0.10+1.10%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs